BK transplant nephropathy successfully treated with cidofovir. |
| |
| Authors: | Lisa S Keller Chen Au Peh James Nolan Kym M Bannister Anthony R Clarkson Randall J Faull |
| |
| Affiliation: | Department of Renal Medicine, Royal Adelaide Hospital, North Terrace, Adelaide, SA 3000, Australia. lkeller@mail.rah.sa.gov.au |
| |
| Abstract: | | Introduction | BK-virus-induced interstitial nephritis (BK nephropathy) isa recently recognized condition affecting renal allografts thatmay lead to graft failure [1]. BK-virus infection is endemicworldwide with seroprevalence rates in normal adults of 6080%[1]. Risk factors for BK nephropathy include high levels ofimmunosuppression, particularly involving tacrolimus [2]. Thereis no established treatment other than reduction of immunosuppressionto aid viral clearance, which risks acute irreversible rejection[3]. There are in vitro data showing that cidofovir inhibitsBK virus replication, but there are
| |
| Keywords: | BK transplant nephropathy BK virus cidofovir renal transplant |
| 本文献已被 Oxford 等数据库收录！ |
|
